[1]
F. Perrotta, “Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study”, Reumatismo, vol. 72, no. 1, pp. 52-59, Apr. 2020.